The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.31BCNY
639.14M · vs all stocks (USD)
Updated Aug 19, 2026
Revenue (TTM)
1.59BCNY
235.08M · vs all stocks (USD)
Updated Aug 19, 2026
Profit Margin
-1.75%
vs Tools & Accessories peers
Updated Aug 19, 2026
Beta
0.2650x
vs all stocks
Updated Aug 19, 2026
52-Week Change
-38.04%
vs all stocks
Updated Aug 19, 2026
Market Capitalization
4.31BCNY
639.14M · vs all stocks (USD)
Updated Aug 19, 2026
Enterprise Value
4.17BCNY
618.20M · vs all stocks (USD)
Updated Aug 19, 2026
Forward P/E
17.21x
vs Tools & Accessories peers
Updated Aug 19, 2026
Price to Sales (TTM)
2.73x
vs Tools & Accessories peers
Updated Aug 19, 2026
Price to Book (MRQ)
3.22x
vs Tools & Accessories peers
Updated Aug 19, 2026
Enterprise to Revenue
2.63x
vs Tools & Accessories peers
Updated Aug 19, 2026
Enterprise to EBITDA
27.97x
vs Tools & Accessories peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 46.38×.Updated Aug 19, 2026
Gross Margin
21.70%
vs Tools & Accessories peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 19.68%.Updated Aug 19, 2026
Profit Margin
-1.75%
vs Tools & Accessories peers
Updated Aug 19, 2026
Operating Margin
8.46%
vs Tools & Accessories peers
Updated Aug 19, 2026
Return on Assets (TTM)
1.89%
vs Tools & Accessories peers
Updated Aug 19, 2026
Return on Equity (TTM)
-2.10%
vs Tools & Accessories peers
Updated Aug 19, 2026
Revenue (TTM)
1.59BCNY
235.08M · vs all stocks (USD)
Updated Aug 19, 2026
Revenue per Share (TTM)
6.30CNYUpdated Aug 19, 2026
Quarterly Revenue Growth
16.20%
vs Tools & Accessories peers
Updated Aug 19, 2026
Gross Profit (TTM)
312.00MCNY
46.27M · vs all stocks (USD)
Updated Aug 19, 2026
EBITDA (TTM)
89.88MCNY
13.33M · vs all stocks (USD)
Updated Aug 19, 2026
Net Income (TTM)
-27.76MCNY
-4.12M · vs all stocks (USD)
Updated Aug 19, 2026
Quarterly Earnings Growth (YoY)
63.40%
vs Tools & Accessories peers
Updated Aug 19, 2026
Operating Cash Flow (TTM)
54.77MCNY
8.12M · vs all stocks (USD)
Updated Aug 19, 2026
Levered Free Cash Flow (TTM)
-95.44MCNY
-14.15M · vs all stocks (USD)
Updated Aug 19, 2026
5-Year Average Dividend Yield
3.14%
vs all stocks
Updated Aug 19, 2026
Payout Ratio
58.82%
vs Tools & Accessories peers
Updated Aug 19, 2026
Minority Interest (Equity)
2.50MCNYFY2025 · Dec 31, 2025
Revenue
1.53BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
1.23BCNYFY2025 · Dec 31, 2025
Gross Profit
295.79MCNYFY2025 · Dec 31, 2025
Operating Income
75.48MCNY
11.19M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-14.20MCNYFY2025 · Dec 31, 2025
Income Tax Expense
23.98MCNYFY2025 · Dec 31, 2025
Net Income
-38.18MCNYFY2025 · Dec 31, 2025
EBIT
-2.67MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
166.22MCNYFY2025 · Dec 31, 2025
Research & Development
72.26MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
54.03MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
12.76MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
1.98MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
11.52MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.1474CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.1474CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
252.73MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
252.73MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-38.18MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
927.46KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-58.95MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-208.54MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
465.14MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-38.18MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
24.53MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-52.67MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
7.37MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-149.59MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-5.05MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-744.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
938.01MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
39.37MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
261.33MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-237.32MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-29.94MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-259.33KCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-6.19MCNYFY2025 · Dec 31, 2025
Shares Outstanding
251.74MSharesUpdated Aug 19, 2026
Float Shares
156.21MSharesUpdated Aug 19, 2026
% Held by Insiders
37.89%
vs all stocks
Updated Aug 19, 2026
% Held by Institutions
1.40%
vs all stocks
Updated Aug 19, 2026
Total Cash (MRQ)
441.33MCNY
65.45M · vs all stocks (USD)
Updated Aug 19, 2026
Total Cash per Share (MRQ)
1.75CNYUpdated Aug 19, 2026
Total Debt (MRQ)
464.03MCNY
68.82M · vs all stocks (USD)
Updated Aug 19, 2026
Total Debt to Equity (MRQ)
0.3445x
vs Tools & Accessories peers
Updated Aug 19, 2026
Current Ratio (MRQ)
1.52x
vs Tools & Accessories peers
Updated Aug 19, 2026
Book Value per Share (MRQ)
5.34CNYUpdated Aug 19, 2026
Total Assets
2.38BCNY
352.84M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.30BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.06BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.08BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
271.17MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
785.61MCNYFY2025 · Dec 31, 2025
Cash
465.14MCNYFY2025 · Dec 31, 2025
Cash Equivalents
5.60MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
470.74MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
250.00KCNYFY2025 · Dec 31, 2025
Accounts Receivable
318.15MCNYFY2025 · Dec 31, 2025
Inventory
260.85MCNYFY2025 · Dec 31, 2025
Accounts Payable
420.74MCNYFY2025 · Dec 31, 2025
Short-term Debt
245.95MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
40.18MCNYFY2025 · Dec 31, 2025
Long-term Debt
191.94MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
90.76KCNYFY2025 · Dec 31, 2025
Common Stock (Book)
251.74MCNYFY2025 · Dec 31, 2025
Retained Earnings
335.39MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.32BCNY
196.12M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
14.36CNYUpdated Aug 19, 2026
52-Week High
30.58CNYUpdated Aug 19, 2026
52-Week Change
-38.04%
vs all stocks
Updated Aug 19, 2026
Beta
0.2650x
vs all stocks
Updated Aug 19, 2026
50-Day MA
19.57CNYUpdated Aug 19, 2026
200-Day MA
21.52CNYUpdated Aug 19, 2026
Avg 10-Day Volume
8.28MSharesUpdated Aug 19, 2026
Avg 30-Day Volume
12.35MSharesUpdated Aug 19, 2026
Diluted EPS (TTM)
-0.1100CNYUpdated Aug 19, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.54: safe zoneNotable
Altman Z-Score: 3.54
Supply Chain
Upstream position: supplies 6 industries, depends on 2Notable
Outgoing: 6.00Incoming: 2.00
Companies that share the same coordination system — how they create, deliver, or capture value.